戻る
AstraZeneca Stock Target Adjusted by Goldman Sachs on Hypophosphatasia Drug Potential
戻る
株式ニュース
テーマ
AstraZeneca Stock Target Adjusted by Goldman Sachs on Hypophosphatasia Drug Potential
AstraZeneca Stock Target Adjusted by Goldman Sachs on Hypophosphatasia Drug Potential
Edgen Stock
·
Sep 28 2025, 03:30
共有先
共有先
リンクをコピー
ソース：
[1] AstraZeneca (AZN) Stock Target Raised as Goldman Sachs Sees $3.7 Billion Drug Potential
[2] Goldman Sachs raises AstraZeneca stock price target on HPP drug potential - Investing.com
[3] Efzimfotase alfa by Alexion Pharmaceuticals for Hypophosphatasia: Likelihood of Approval
Edgen Stock·Sep 28 2025, 03:30